Frazier Life Sciences Acquisition Corp. II Capital Raise of $78M
Frazier Life Sciences Acquisition Corp. II completed its initial public offering of 7,500,000 Class A ordinary shares and a simultaneous private placement of 300,000 shares to its sponsor, generating total gross proceeds of $78 million. Of these proceeds, $75 million was deposited into a U.S.-based trust account for the benefit of public shareholders.
Frazier Life Sciences Acquisition Corp. II CEO Albert Cha Buys $3M of Stock
Albert Cha, CEO, bought 300,000 shares of Frazier Life Sciences Acquisition Corp. II at $10.00 a share, worth $3M in total on Oct 15, 2026. Shares held after the trade: 300,000.
Frazier Life Sciences Acquisition Corp. II Capital Raise of $78M
Frazier Life Sciences Acquisition Corp. II consummated its initial public offering (IPO) of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds. Simultaneously, the company's sponsor purchased 300,000 private placement shares for an additional $3 million, and a forward purchase agreement was established for at least $25 million to be funded at the time of a future business combination.